LeConte Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Buy
3,534
+447
+14% +$51.6K 0.27% 66
2025
Q4
$325K Buy
3,087
+309
+11% +$29K 0.21% 75
2025
Q3
$233K Buy
+2,778
New +$229K 0.16% 112

Other funds holding MRK

LeConte Wealth Management's MRK Position: Q1 2026 in Review

LeConte Wealth Management increased its Merck (MRK) stake by 14% in Q1 2026, buying an estimated $51.6K and bringing the position to 3,534 shares worth $425K. The position accounts for 0.27% of the portfolio, ranked #66.

LeConte Wealth Management first reported a position in MRK in Q3 2025 and has held it in 3 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • LeConte Wealth Management held 3,534 shares of Merck worth $425K as of Q1 2026.
  • LeConte Wealth Management bought 447 Merck shares in Q1 2026, an estimated $51.6K.
  • Merck made up 0.27% of LeConte Wealth Management's portfolio in Q1 2026, its #66 holding.
  • LeConte Wealth Management first reported a position in Merck in Q3 2025 and has held it in 3 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.